Eur Rev Med Pharmacol Sci 2019; 23 (2): 630-640

DOI: 10.26355/eurrev_201901_16877

MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma

L. Ji, Z.-N. Zhu, C.-J. He, X. Shen

Department of General Dentistry, The Affiliated Stomatological Hospital of Nanchang University, Nanchang, China. sdlcjl516@126.com


OBJECTIVE: Recently, increased microRNAs have been shown to play an important role in the pathogenesis and progression of human cancers, including oral squamous cell carcinoma (OSCC). In this study, we focused on the function of microRNA-127-3p (miR-127-3p) associated with OSCC carcinogenesis.

PATIENTS AND METHODS: MiR-127-3p and KIF3B expressions were observed via quantitative Real-time polymerase chain reaction (qRT-PCR) or Western blot in OSCC. The functions of mR-127-3p and KIF3B were investigated through MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and transwell assays. And luciferase reporter assay was performed to confirm the relationship between mR-127-3p and KIF3B.

RESULTS: First, down-regulation of miR-127-3p was identified in OSCC, which was associated with malignant clinicopathological features and poor prognosis in OSCC patients. Functionally, overexpression of miR-127-3p led to inhibition of cell proliferation and metastasis in OSCC. Further, KIF3B was confirmed to be a direct target of miR-127-3p. Moreover, upregulation of KIF3B was also observed in OSCC, which promoted tumorigenesis of OSCC. In particular, the upregulation of KIF3B partially attenuated the inhibitory effect of miR-127-3p on the development of OSCC.

CONCLUSIONS: MiR-127-3p targeted KIF3B to inhibit the development of OSCC through suppressing cell proliferation, migration and invasion.

Free PDF Download

To cite this article

L. Ji, Z.-N. Zhu, C.-J. He, X. Shen
MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 2
Pages: 630-640
DOI: 10.26355/eurrev_201901_16877